Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity

por Kamerkar, Sushrut, Leng, Charan, Burenkova, Olga, Jang, Su Chul, McCoy, Christine, Zhang, Kelvin, Dooley, Kevin, Kasera, Samuel, Zi, Tong, Sisó, Sílvia, Dahlberg, William, Sia, Chang Ling, Patel, Shil, Schmidt, Karl, Economides, Kyriakos, Soos, Timothy, Burzyn, Dalia, Sathyanarayanan, Sriram
Publicado 2022

A versatile platform for generating engineered extracellular vesicles with defined therapeutic properties

por Dooley, Kevin, McConnell, Russell E., Xu, Ke, Lewis, Nuruddeen D., Haupt, Sonya, Youniss, Madeleine R., Martin, Shelly, Sia, Chang Ling, McCoy, Christine, Moniz, Raymond J., Burenkova, Olga, Sanchez-Salazar, Jorge, Jang, Su Chul, Choi, Bryan, Harrison, Rane A., Houde, Damian, Burzyn, Dalia, Leng, Charan, Kirwin, Katherine, Ross, Nikki L., Finn, Jonathan D., Gaidukov, Leonid, Economides, Kyriakos D., Estes, Scott, Thornton, James E., Kulman, John D., Sathyanarayanan, Sriram, Williams, Douglas E.
Publicado 2021